Where Global Healthcare Leaders Shape What’s Next

Co-founder | Emeritus Professor | Senior Researcher at Original Blue Zones Hotspot | Université Catholique de Louvain

Award-winning scientist and co-discoverer of the Blue Zones, redefined global longevity research. His pioneering work validating the world’s longest-living populations set the gold standard for aging science and is featured in Netflix’s Live to 100: Secrets of the Blue Zones.

Chief Executive Officer at The View Hospital

Recognized by Forbes as one of the Top 50 Healthcare Leaders
Led the launch of Fakeeh University Hospital the Middle East's first environmentally friendly, LEED-certified university hospital
Founded CSR Middle East in 2005. He is one of the most active supporters of King Charles’s Terra Carta initiative

President, Diversified Businesses and Senior Vice President at Mass General Brigham

Aaron is the strategic force behind Mass General Brigham's diversified healthcare portfolio, leveraging his physician background and entrepreneurial success to transform care delivery models. His leadership spans founding multiple healthcare ventures and orchestrating $110M+ business portfolios that bridge clinical innovation with sustainable growth strategies.

Global Director of Healthcare Solutions at Google

Aashima Gupta is a Global visionary driving AI-first transformation across the healthcare and life sciences ecosystem. Aashima has been named one of the Five Most Influential Women in Health IT by HIMSS and Top 30 Healthcare Leaders in Healthcare.

CEO & Chairman at TVM Capital Healthcare

Dr. Schuehsler is a pioneering investor and operator, shaping the global healthcare landscape. As Chairman & CEO of TVM Capital Healthcare, he has directed over $2B in global healthcare investments, building hospitals and care networks across the Middle East and Asia and establishing himself as one of the foremost voices in healthcare private equity.

Chief Health Officer at IBM

President & CEO, Healthcare Management Group at McLaren Healthcare Group

President & CEO of McLaren Health Management Group, part of McLaren Health Care, one of Michigan’s largest integrated health systems with 12 hospitals, 250+ sites of care, and over 113,000 network providers extending into Indiana. Under his leadership, McLaren has pioneered telehealth transformation, seamlessly expanding access to rural and urban communities alike, and driven major investments including a $35 million Oakland–Oxford medical campus. With the nationally renowned Karmanos Cancer Institute anchoring the system, Buxton has been at the forefront of advancing population health, innovation, and care delivery at scale.

President | Founder & CEO at Saudi Sports for All Federation (SFA) | KBW Ventures

President and CEO at Houston Methodist Global Health Care Services

WW Vice President & Managing Director Middle East & Africa at Johnson & Johnson

Associate Vice President and Professor of Chemical Pathology at The Chinese University of Hong Kong

Professor Allen K.C. Chan is a globally acclaimed clinician-scientist and biotech innovator, co-inventor of over 120 groundbreaking inventions in noninvasive prenatal testing and cancer detection, with a staggering portfolio of over 1,500 patents granted worldwide; his work, adopted in over 90 countries, has transformed global diagnostics and earned him recognition among Nature Biotechnology’s Top 20 Translational Researchers.

Public Health Professor and Advisor at Real World Health

Global public health leader and architect of award-winning NCD strategies, with 30 years’ impact across the UN, WHO, WEF, and GCC governments. She bridges policy, precision health, and innovation to drive systemic change in how populations prevent and manage chronic disease.

Founding Partner at Maximon

Physician-scientist and longevity innovator where she leads the development of science-backed longevity ventures at Maximon. Recipient of the Margot and Erich Goldschmidt & Peter René Jacobson Foundation Award for excellence in medical research. Patent co-inventor: Method for enhancing skin pigmentation via redox modulation in melanocytes Published in high-impact journals on melanoma, NAD+ longevity strategies, and COVID-related diagnostic delays

Chief Technology Advisor at Ageing Australia

Medical doctor with strong experience in software development and marketing. Interest in improving quality and delivery of healthcare utilising information technology.
Currently involved in development and implementation of innovative healthcare solutions delivered over the internet.

Professor and Consultant Medical Oncologist at University College London Hospitals/UCL

Professor Siow Ming Lee serves as Professor of Medical Oncology at University College London (UCL) and Consultant Medical Oncologist at University College London Hospitals (UCLH). He specializes in lung cancer treatment and research, having designed and led numerous groundbreaking clinical trials over more than two decades.
An internationally recognized authority in his field, Professor Lee was honored with the British Thoracic Oncology Group's Lifetime Achievement Award for his exceptional contributions to lung cancer research. His work has influenced treatment paradigms and improved outcomes for lung cancer patients, with particular expertise in immunotherapy, targeted treatments, and DNA repair pathways.

FIFA Medical Lead at Federation Internationale de Football Associations FIFA

Directs all medical services planning and implementation at FIFA tournaments globally, focusing on athlete health and performance. serves on the Union of European Football Associations’ Therapeutic Use Exemption Committee and is a member of the Board of Directors at the Center for Sports Equity at Stanford.

Member of the House of Lords and Chair of Genomics England

The first female MP for Oxford and former Health Minister & Minister of Innovation, now leads as Chair of Genomics England while serving on the boards of Oxford University Innovation and biotechnology pioneer BioNTech. As a member of the House of Lords, she continues to shape science and innovation policy through her distinguished leadership roles.

Global Chief Medical Officer & VP of Healthcare at Microsoft

Dr. David is the architect behind Microsoft's global health strategy, leading efforts that have transformed digital healthcare across 190+ countries. Twice named one of Modern Healthcare's 100 Most Influential People in Healthcare, he holds six U.S. technology patents in electronic health records and clinical AI and has been a driving force behind some of the most impactful public-private partnerships in health innovation today.

CEO at Great Ormond Street Hospital for Children NHS Foundation Trust

Matthew is the CEO of Great Ormond Street Hospital, ranked the No.1 children's hospital in Europe and 6th globally where he leads one of the world's most iconic pediatric institutions, driving breakthroughs in rare disease, complex surgery, and child health innovation.